CHENG XIN JIANG: Open Payments
NPI 1174043301 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,108 in 54 payments from 26 companies in 2025. Trend: 2023 $903 · 2024 $994 · 2025 $1,108
Food & beverage: $1,108
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $208 |
| Novartis Pharmaceuticals Corporation | 4 | $114 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| PFIZER INC. | 4 | $85 |
| Aimmune Therapeutics, Inc. | 3 | $60 |
| Verity Pharmaceuticals Inc. | 1 | $55 |
| Amgen Inc. | 3 | $49 |
| Lilly USA, LLC | 2 | $48 |
| Novo Nordisk Inc | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $37 |
Products named: LEQVIO, QULIPTA, UBRELVY, Trelstar, MOUNJARO, PREVNAR 20, ELIQUIS, Wegovy.
Industry payments across MO — which companies pay providers there.
